EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 80 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,168 | +3.9% | 24,714 | +36.7% | 0.00% | – |
| Q4 2022 | $21,330 | -84.1% | 18,076 | +1.6% | 0.00% | – |
| Q3 2022 | $134,000 | +3.9% | 17,798 | -13.3% | 0.00% | – |
| Q2 2022 | $129,000 | -10.4% | 20,535 | +18.2% | 0.00% | – |
| Q1 2022 | $144,000 | +42.6% | 17,374 | -10.6% | 0.00% | – |
| Q4 2021 | $101,000 | -17.9% | 19,432 | +5.6% | 0.00% | – |
| Q3 2021 | $123,000 | -24.1% | 18,410 | -3.0% | 0.00% | – |
| Q2 2021 | $162,000 | -13.4% | 18,981 | -10.5% | 0.00% | – |
| Q1 2021 | $187,000 | -34.2% | 21,215 | -8.1% | 0.00% | – |
| Q4 2020 | $284,000 | +127.2% | 23,080 | +49.7% | 0.00% | – |
| Q3 2020 | $125,000 | +12.6% | 15,417 | +32.9% | 0.00% | – |
| Q2 2020 | $111,000 | -69.0% | 11,600 | -78.0% | 0.00% | – |
| Q1 2020 | $358,000 | +86.5% | 52,683 | +306.4% | 0.00% | – |
| Q4 2019 | $192,000 | +186.6% | 12,963 | +94.8% | 0.00% | – |
| Q3 2019 | $67,000 | -77.1% | 6,656 | -76.1% | 0.00% | – |
| Q2 2019 | $293,000 | -28.9% | 27,828 | -5.7% | 0.00% | – |
| Q1 2019 | $412,000 | -7.0% | 29,523 | -32.4% | 0.00% | – |
| Q4 2018 | $443,000 | -66.2% | 43,700 | -60.0% | 0.00% | – |
| Q3 2018 | $1,310,000 | -6.5% | 109,168 | -5.0% | 0.00% | – |
| Q2 2018 | $1,401,000 | – | 114,900 | +1044445.5% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 11 | -99.9% | 0.00% | – |
| Q4 2017 | $162,000 | -84.0% | 11,631 | -87.4% | 0.00% | -100.0% |
| Q3 2017 | $1,014,000 | +156.7% | 92,212 | +84.4% | 0.00% | – |
| Q2 2017 | $395,000 | -13.8% | 50,020 | +24.6% | 0.00% | – |
| Q1 2017 | $458,000 | -3.4% | 40,135 | -1.9% | 0.00% | – |
| Q4 2016 | $474,000 | +28.5% | 40,901 | +47.9% | 0.00% | – |
| Q3 2016 | $369,000 | -41.1% | 27,663 | -12.8% | 0.00% | – |
| Q2 2016 | $627,000 | +129.7% | 31,714 | +94.5% | 0.00% | – |
| Q1 2016 | $273,000 | – | 16,303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |